US Patent

US9701538 — Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)

Formulation · Assigned to Geno LLC · Expires 2029-01-28 · 3y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a system for converting nitrogen dioxide to nitric oxide using a surface-active material coated with an aqueous solution of ascorbic acid and an absorbent.

USPTO Abstract

Various systems, devices, NO 2 absorbents, NO 2 scavengers and NO 2 recuperator for generating nitric oxide are disclosed herein. According to one embodiment, an apparatus for converting nitrogen dioxide to nitric oxide can include a receptacle including an inlet, an outlet, a surface-active material coated with an aqueous solution of ascorbic acid and an absorbent wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the surface-active material and the absorbent such that nitrogen dioxide in the gas flow is converted to nitric oxide.

Drugs covered by this patent

Patent Metadata

Patent number
US9701538
Jurisdiction
US
Classification
Formulation
Expires
2029-01-28
Drug substance claim
No
Drug product claim
Yes
Assignee
Geno LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.